
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported in December 2019 and causes coronavirus (CoV) disease 2019 (COVID-19). The virus transmits rapidly in humans and has ...
Pharmacology, SARS-CoV-2, Clinical Biochemistry, COVID-19, Virus Internalization, Antibodies, Neutralizing, Antiviral Agents, COVID-19 Drug Treatment, Drug Discovery, Spike Glycoprotein, Coronavirus, Molecular Medicine, Humans
Pharmacology, SARS-CoV-2, Clinical Biochemistry, COVID-19, Virus Internalization, Antibodies, Neutralizing, Antiviral Agents, COVID-19 Drug Treatment, Drug Discovery, Spike Glycoprotein, Coronavirus, Molecular Medicine, Humans
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 56 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 1% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 1% |
